We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Neumora Therapeutics
NMRA
$317M
| $230K | ﹤0.01% |
21,700
-4,900
| -18% | -$58.7K |
|
1502
Bank of N.T. Butterfield & Son
NTB
$2.5B
| $230K | ﹤0.01% |
+6,300
| New | +$236K |
|
1503
Sprinklr
CXM
$1.58B
| $229K | ﹤0.01% |
27,100
| – | – |
|
1504
First Advantage
FA
$3.61B
| $229K | ﹤0.01% |
12,200
| – | – |
|
1505
National Bank Holdings
NBHC
$1.92B
| $224K | ﹤0.01% |
+5,200
| New | +$235K |
|
1506
TriCo Bancshares
TCBK
$1.84B
| $218K | ﹤0.01% |
+5,000
| New | +$228K |
|
1507
Mercury Insurance
MCY
$5.84B
| $217K | ﹤0.01% |
3,258
| – | – |
|
1508
Apogee Enterprises
APOG
$897M
| $210K | ﹤0.01% |
2,944
| – | – |
|
1509
Autohome
ATHM
$2.65B
| $202K | ﹤0.01% |
7,797
| – | – |
|
1510
StoneX
SNEX
$8.37B
| $202K | ﹤0.01% |
+6,966
| New | +$195K |
|
1511
StoneCo
STNE
$2.43B
| $199K | ﹤0.01% |
24,947
| – | – |
|
1512
Canadian Solar
CSIQ
$1.07B
| $198K | ﹤0.01% |
17,800
-1,900
| -10% | -$24.5K |
|
1513
LegalZoom.com
LZ
$930M
| $191K | ﹤0.01% |
25,400
| – | – |
|
|
NVEE
1514
DELISTED
NV5 Global
NVEE
| $190K | ﹤0.01% |
10,100
-1,100
| -10% | -$24.1K |
|
1515
American Express Global Business Travel
GBTG
$4.93B
| $182K | ﹤0.01% |
+19,600
| New | +$167K |
|
1516
SolarEdge
SEDG
$1.97B
| $180K | ﹤0.01% |
13,258
-201,110
| -94% | -$3.1M |
|
|
JAMF
1517
DELISTED
Jamf
JAMF
| $176K | ﹤0.01% |
12,506
| – | – |
|
1518
Adecoagro
AGRO
$1.34B
| $175K | ﹤0.01% |
18,558
| – | – |
|
1519
Constellium
CSTM
$4B
| $175K | ﹤0.01% |
17,000
+1,500
| +10% | +$18.4K |
|
1520
NET Power
NPWR
$144M
| $175K | ﹤0.01% |
+16,500
| New | +$162K |
|
|
AUTL
1521
Autolus Therapeutics
AUTL
$564M
| $172K | ﹤0.01% |
73,300
+17,300
| +31% | +$58.5K |
|
1522
Keros Therapeutics
KROS
$222M
| $171K | ﹤0.01% |
10,800
+1,100
| +11% | +$57.2K |
|
1523
Liberty Latin America Class A
LILA
$1.69B
| $171K | ﹤0.01% |
39,597
| – | – |
|
1524
Plug Power
PLUG
$3.2B
| $171K | ﹤0.01% |
80,400
| – | – |
|
1525
Tronox
TROX
$985M
| $167K | ﹤0.01% |
16,600
| – | – |
|
Similar funds
VIA
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.